How a combination of covid lawsuits and media coverage keeps misinformation churning

FHS
July 14, 2023
10:43 am

Public health has had its day in court lately. And another day. And another day.

Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

March 29, 2024

Stelara® Biosimilar Candidate FYB202 (Ustekinumab) receives positive CHMP opinion from EMA – Biotech Investments

Formycon AG / Key word(s): Statement/Regulatory Admission Stelara® Biosimilar Candidate FYB202 (Ustekinumab) receives positive CHMP opinion from EMA 26-Jul-2024 / 10:54 CET/CEST Disclosure of an

July 27, 2024

STAT investigative series ‘Denied by AI’ wins major journalism prizes

Dear Readers, Please bear with me as I brag about two of STAT’s most accomplished (and humble) reporters: Casey Ross and Bob Herman. advertisement This

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.